Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ly2606368
1. Ly2606368
2. 1234015-52-1
3. Prexasertib [usan]
4. Ly-2606368
5. 5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1h-pyrazol-3-yl]amino]pyrazine-2-carbonitrile
6. 820nh671e6
7. Prexasertib (ly2606368)
8. 5-((5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1h-pyrazol-3-yl)amino)pyrazine-2-carbonitrile
9. 5-({5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1h-pyrazol-3-yl}amino)pyrazine-2-carbonitrile
10. 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1h-pyrazol-3-ylamino)pyrazine-2-carbonitrile
11. Ly2606368 Mesylate Monohydrate
12. Unii-820nh671e6
13. 2-pyrazinecarbonitrile, 5-((5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1h-pyrazol-3-yl)amino)-
14. 2-pyrazinecarbonitrile, 5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1h-pyrazol-3-yl]amino]-
15. Prexasertib [inn]
16. Prexasertib (usan/inn)
17. Ly2606368;prexasertib
18. Prexasertib [who-dd]
19. Gtpl9549
20. Schembl1975451
21. Chembl3544911
22. Schembl18989301
23. Schembl19457660
24. Ex-a758
25. Dtxsid301031326
26. Bcp14380
27. Bdbm50524300
28. Mfcd25977016
29. Nsc758257
30. Nsc789570
31. Zinc95837013
32. Db12008
33. Nsc-758257
34. Nsc-789570
35. Sb16662
36. Ncgc00390643-02
37. Ncgc00390643-06
38. Ac-35534
39. Hy-18174
40. Db-100131
41. Ft-0700138
42. Ly 2606368;ly-2606368;prexasertib
43. J3.517.082k
44. D11206
45. J-690088
46. Q27269284
47. 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1h-pyrazol-3-yl)amino)pyrazine-2- Carbonitrile
48. 5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1h-pyrazol-3-yl]amino]-2-pyrazinecarbonitrile
49. Sodium (2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-5-yl)phosphonate
Molecular Weight | 365.4 g/mol |
---|---|
Molecular Formula | C18H19N7O2 |
XLogP3 | 1.4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 8 |
Exact Mass | 365.16002287 g/mol |
Monoisotopic Mass | 365.16002287 g/mol |
Topological Polar Surface Area | 135 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 499 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
ABOUT THIS PAGE
41
PharmaCompass offers a list of Prexasertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Prexasertib manufacturer or Prexasertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Prexasertib manufacturer or Prexasertib supplier.
PharmaCompass also assists you with knowing the Prexasertib API Price utilized in the formulation of products. Prexasertib API Price is not always fixed or binding as the Prexasertib Price is obtained through a variety of data sources. The Prexasertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Prexasertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prexasertib, including repackagers and relabelers. The FDA regulates Prexasertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prexasertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Prexasertib supplier is an individual or a company that provides Prexasertib active pharmaceutical ingredient (API) or Prexasertib finished formulations upon request. The Prexasertib suppliers may include Prexasertib API manufacturers, exporters, distributors and traders.
Prexasertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prexasertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prexasertib GMP manufacturer or Prexasertib GMP API supplier for your needs.
A Prexasertib CoA (Certificate of Analysis) is a formal document that attests to Prexasertib's compliance with Prexasertib specifications and serves as a tool for batch-level quality control.
Prexasertib CoA mostly includes findings from lab analyses of a specific batch. For each Prexasertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prexasertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Prexasertib EP), Prexasertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prexasertib USP).